BACKGROUND: An inverse association between selenium status and incidence of different neoplasias including gastric cancer has been reported. This pilot study aimed to determine and compare selenium status in two Colombian populations with different gastric cancer risks: a high-risk area in the volcanic region of the Andes Mountains and a low-risk area on the Pacific coast. METHODS: Eighty nine adult males were recruited in the outpatient clinics of two public hospitals (44 and 45 from high- and low-risk areas, respectively) and provided a blood sample. Seventy one (79.8%) participants underwent upper gastrointestinal endoscopy. Plasma selenium was assayed using a fluorometric method, selenoprotein-P by ELISA, and glutathione peroxidase activity by a spectrophometric method. Histological diagnosis and Helicobacter pylori infection were evaluated in gastric biopsy samples. Unpaired samples t-test and linear regression analyses were used for statistical analyses. RESULTS: Although none of the subjects in either of the two geographic areas was selenium deficient, the level of plasma selenium was significantly lower in men from the high-risk area compared with those from the low-risk area. Levels of selenoprotein-P and glutathione peroxidase activity were similar between groups after adjustment for confounders. Selenium measurements were not associated with histopathological diagnosis. CONCLUSIONS: The high incidence of gastric cancer in the Andean region of Colombia is unlikely to be explained by selenium deficiency. We cannot exclude, however, that suboptimal selenium levels may exist in the gastric mucosa of subjects in the high-risk area. Therefore, the benefit of selenium supplementation in gastric cancer prevention cannot be dismissed.
BACKGROUND: An inverse association between selenium status and incidence of different neoplasias including gastric cancer has been reported. This pilot study aimed to determine and compare selenium status in two Colombian populations with different gastric cancer risks: a high-risk area in the volcanic region of the Andes Mountains and a low-risk area on the Pacific coast. METHODS: Eighty nine adult males were recruited in the outpatient clinics of two public hospitals (44 and 45 from high- and low-risk areas, respectively) and provided a blood sample. Seventy one (79.8%) participants underwent upper gastrointestinal endoscopy. Plasma selenium was assayed using a fluorometric method, selenoprotein-P by ELISA, and glutathione peroxidase activity by a spectrophometric method. Histological diagnosis and Helicobacter pylori infection were evaluated in gastric biopsy samples. Unpaired samples t-test and linear regression analyses were used for statistical analyses. RESULTS: Although none of the subjects in either of the two geographic areas was selenium deficient, the level of plasma selenium was significantly lower in men from the high-risk area compared with those from the low-risk area. Levels of selenoprotein-P and glutathione peroxidase activity were similar between groups after adjustment for confounders. Selenium measurements were not associated with histopathological diagnosis. CONCLUSIONS: The high incidence of gastric cancer in the Andean region of Colombia is unlikely to be explained by selenium deficiency. We cannot exclude, however, that suboptimal selenium levels may exist in the gastric mucosa of subjects in the high-risk area. Therefore, the benefit of selenium supplementation in gastric cancer prevention cannot be dismissed.
Authors: M Rugge; P Correa; M F Dixon; T Hattori; G Leandro; K Lewin; R H Riddell; P Sipponen; H Watanabe Journal: Am J Surg Pathol Date: 2000-02 Impact factor: 6.394
Authors: S D Mark; Y L Qiao; S M Dawsey; Y P Wu; H Katki; E W Gunter; J F Fraumeni; W J Blot; Z W Dong; P R Taylor Journal: J Natl Cancer Inst Date: 2000-11-01 Impact factor: 13.506
Authors: J D Brooks; E J Metter; D W Chan; L J Sokoll; P Landis; W G Nelson; D Muller; R Andres; H B Carter Journal: J Urol Date: 2001-12 Impact factor: 7.450
Authors: Catherine Méplan; Lynne K Crosley; Fergus Nicol; Geoffrey J Beckett; Alexander F Howie; Kristina E Hill; Graham Horgan; John C Mathers; John R Arthur; John E Hesketh Journal: FASEB J Date: 2007-05-29 Impact factor: 5.191
Authors: Thibaut de Sablet; M Blanca Piazuelo; Carrie L Shaffer; Barbara G Schneider; Mohammad Asim; Rupesh Chaturvedi; Luis E Bravo; Liviu A Sicinschi; Alberto G Delgado; Robertino M Mera; Dawn A Israel; Judith Romero-Gallo; Richard M Peek; Timothy L Cover; Pelayo Correa; Keith T Wilson Journal: Gut Date: 2011-02-25 Impact factor: 23.059
Authors: John T Loh; Carrie L Shaffer; M Blanca Piazuelo; Luis E Bravo; Mark S McClain; Pelayo Correa; Timothy L Cover Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-08-22 Impact factor: 4.254
Authors: Javier Torres; Pelayo Correa; Catterina Ferreccio; Gustavo Hernandez-Suarez; Rolando Herrero; Maria Cavazza-Porro; Ricardo Dominguez; Douglas Morgan Journal: Cancer Causes Control Date: 2012-12-07 Impact factor: 2.506
Authors: Ines Yang; Sabrina Woltemate; M Blanca Piazuelo; Luis E Bravo; Maria Clara Yepez; Judith Romero-Gallo; Alberto G Delgado; Keith T Wilson; Richard M Peek; Pelayo Correa; Christine Josenhans; James G Fox; Sebastian Suerbaum Journal: Sci Rep Date: 2016-01-05 Impact factor: 4.379
Authors: Robert Sitarz; Małgorzata Skierucha; Jerzy Mielko; G Johan A Offerhaus; Ryszard Maciejewski; Wojciech P Polkowski Journal: Cancer Manag Res Date: 2018-02-07 Impact factor: 3.989